FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802051290> ?p ?o ?g. }

• W2802051290 endingPage "112" @default.
• W2802051290 startingPage "95" @default.
• W2802051290 abstract "The aim of this study was to evaluate the surgical handling and clinical applicability of a specific 3D-printed membrane design fabricated using a gelatin, elastin and sodium hyaluronate blend for conjunctival reconstruction and compare it with amniotic membrane (AM), which is normally used in such surgeries. 3D printing technique was employed to fabricate the membrane based on gradient design. Prior to printing, rheometry was employed to optimize the ink composition. The printed membranes were then fully characterized in terms of physical and mechanical properties. In vitro viability, proliferation and adhesion of human limbal epithelial cells were assessed using MTT assay and scanning electron microscopy (SEM), respectively. Prior to in vivo experiment, surgical handling of each membrane was evaluated by three surgeons. In vivo evaluation was conducted through implanting the gelatin-based membranes and AM on induced conjunctival defects in rabbits (n = 8). Clinical observations, including epithelialization, inflammation severity, scar tissue formation and presence of granulation tissue, were recorded from day 1 through day 28. Histological examination was performed on all enucleated eyes on day 28. In addition to H&E staining, specific stains including Periodic Acid Schiff staining, Masson's Trichrome staining and immuno-histochemical staining for α-SMA were further used to assess goblet cell proliferation, healed sub-epithelial stroma and scar tissue formation and the presence of myofibroblasts, respectively. Among all the examined compositions, a blend of 8% w/v gelatin, 2% w/v elastin and 0.5% w/v sodium hyaluronate was found to be appropriate for printing. The printed membranes had favorable optical characteristics (colorless and transparent), and the surgical handling was significantly easier compared to AM. Epithelial cells cultivated on the membranes indicated suitable viability and proliferation, and SEM images presented appropriate cell adhesion on the surface of the membranes. Clinical observations suggested similar epithelialization time (approximately 3 weeks) for both the membrane and AM grafted eyes but significantly lower levels of clinical inflammation in the membrane group from day 1 through day 28 (p = 0.01), which is a key advantage of using the printed membranes over the AM. Histological examination showed similar qualities in the healed epithelium in terms of cell morphology and cell layers. However, twice the density of goblet cells per 100 cells was observed in the gelatin-based membrane grafted group. Remnant of the degraded implant was seen in only 3 of the membranes, but in 7 of the AM grafted eyes. Inflammation and granulomatous reaction was significantly higher in sections containing the AM compared to membrane (p < 0.01 and p = 0.01, respectively). α-SMA staining was more evident, but not significantly different from the gelatin-based membrane, for the AM group (p = 0.25). The designed gelatin-based membrane offers the necessary physical and mechanical characteristics needed for successful ocular surface/conjunctival defect construction and may be considered a promising alternative to AM due to a more predictable degradation pattern, higher goblet cell density on the healed epithelium, less inflammation and reduced scar tissue formation." @default.
• W2802051290 created "2018-05-17" @default.
• W2802051290 creator A5000327275 @default.
• W2802051290 creator A5003426381 @default.
• W2802051290 creator A5016583271 @default.
• W2802051290 creator A5033439830 @default.
• W2802051290 creator A5035838725 @default.
• W2802051290 creator A5050680531 @default.
• W2802051290 creator A5053369498 @default.
• W2802051290 creator A5053420360 @default.
• W2802051290 creator A5065499122 @default.
• W2802051290 creator A5084584842 @default.
• W2802051290 creator A5085662088 @default.
• W2802051290 creator A5089618399 @default.
• W2802051290 date "2018-08-01" @default.
• W2802051290 modified "2023-10-16" @default.
• W2802051290 title "3D-Printed membrane as an alternative to amniotic membrane for ocular surface/conjunctival defect reconstruction: An in vitro & in vivo study" @default.
• W2802051290 cites W1527546526 @default.
• W2802051290 cites W1705586769 @default.
• W2802051290 cites W1965334368 @default.
• W2802051290 cites W1970914202 @default.
• W2802051290 cites W1972147971 @default.
• W2802051290 cites W1972478740 @default.
• W2802051290 cites W1972947079 @default.
• W2802051290 cites W1972966166 @default.
• W2802051290 cites W1973764628 @default.
• W2802051290 cites W1973810662 @default.
• W2802051290 cites W1974159545 @default.
• W2802051290 cites W1975479312 @default.
• W2802051290 cites W1980490164 @default.
• W2802051290 cites W1982627594 @default.
• W2802051290 cites W1983715643 @default.
• W2802051290 cites W1986860180 @default.
• W2802051290 cites W1989096090 @default.
• W2802051290 cites W1991367509 @default.
• W2802051290 cites W1995253328 @default.
• W2802051290 cites W1996449673 @default.
• W2802051290 cites W1997799788 @default.
• W2802051290 cites W2000520429 @default.
• W2802051290 cites W2003948328 @default.
• W2802051290 cites W2004209532 @default.
• W2802051290 cites W2004698731 @default.
• W2802051290 cites W2009430131 @default.
• W2802051290 cites W2010930835 @default.
• W2802051290 cites W2013667455 @default.
• W2802051290 cites W2016655994 @default.
• W2802051290 cites W2021192940 @default.
• W2802051290 cites W2024431976 @default.
• W2802051290 cites W2025215630 @default.
• W2802051290 cites W2027701571 @default.
• W2802051290 cites W2033483385 @default.
• W2802051290 cites W2036146053 @default.
• W2802051290 cites W2037255761 @default.
• W2802051290 cites W2049300565 @default.
• W2802051290 cites W2049654243 @default.
• W2802051290 cites W2060627231 @default.
• W2802051290 cites W2065069982 @default.
• W2802051290 cites W2065789311 @default.
• W2802051290 cites W2069553183 @default.
• W2802051290 cites W2070983493 @default.
• W2802051290 cites W2073795225 @default.
• W2802051290 cites W2078714250 @default.
• W2802051290 cites W2080098807 @default.
• W2802051290 cites W2081812417 @default.
• W2802051290 cites W2084516076 @default.
• W2802051290 cites W2084651465 @default.
• W2802051290 cites W2092473547 @default.
• W2802051290 cites W2099642484 @default.
• W2802051290 cites W2108732957 @default.
• W2802051290 cites W2135666758 @default.
• W2802051290 cites W2136441104 @default.
• W2802051290 cites W2144815200 @default.
• W2802051290 cites W2148655151 @default.
• W2802051290 cites W2164311458 @default.
• W2802051290 cites W2195403927 @default.
• W2802051290 cites W2206767262 @default.
• W2802051290 cites W2251769617 @default.
• W2802051290 cites W2256533910 @default.
• W2802051290 cites W2329696961 @default.
• W2802051290 cites W2339501161 @default.
• W2802051290 cites W2343455989 @default.
• W2802051290 cites W2462762182 @default.
• W2802051290 cites W2468110235 @default.
• W2802051290 doi "https://doi.org/10.1016/j.biomaterials.2018.05.013" @default.
• W2802051290 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29793112" @default.
• W2802051290 hasPublicationYear "2018" @default.
• W2802051290 type Work @default.
• W2802051290 sameAs 2802051290 @default.
• W2802051290 citedByCount "50" @default.
• W2802051290 countsByYear W28020512902018 @default.
• W2802051290 countsByYear W28020512902019 @default.
• W2802051290 countsByYear W28020512902020 @default.
• W2802051290 countsByYear W28020512902021 @default.
• W2802051290 countsByYear W28020512902022 @default.
• W2802051290 countsByYear W28020512902023 @default.
• W2802051290 crossrefType "journal-article" @default.
• W2802051290 hasAuthorship W2802051290A5000327275 @default.
• W2802051290 hasAuthorship W2802051290A5003426381 @default.

• next